Medindia

X

/C O R R E C T I O N -- Capital Health System/

Wednesday, November 19, 2008 General News J E 4
Advertisement
In the news release, Advanced Stroke Care Now Available to Area Residents,issued earlier today by Capital Health System over PR Newswire, we are advisedby the company that the phone number for Dr. Veznedaroglu and Dr. Liebman inthe last paragraph should be 609-588-5081, rather than 609-528-5081, asoriginally issued inadvertently. Complete, corrected release follows:

TRENTON, N.J., Nov. 18 /PRNewswire/ -- Capital Health System announcedtoday that two nationally recognized neurosurgeons, specializing incerebrovascular disease, have joined its staff, making it the leading providerin central and southern New Jersey and Bucks County Pennsylvania for advancedtreatment of stroke, aneurysms, and other critical conditions involving thebrain.

Dr. Erol Veznedaroglu and Dr. Kenneth M. Liebman, both recently joinedCapital Health, along with their team of specially trained nurses and clinicalstaff, and have opened the Stroke and Cerebrovascular Center of New Jersey.Veznedaroglu was formerly director of the Division of Neurovascular Surgeryand Endovascular Neurosurgery at Jefferson University Hospitals and Liebmanwas assistant professor of Neurosurgery at Jefferson Medical School.

"There has been a significant void in this region when it comes to theadvanced treatment of strokes and other life-threatening brain conditions,with most patients having to leave the state to get the highest level ofcare," said Al Maghazehe, CEO & President of Capital Health. "With theaddition of Dr. Veznedaroglu and Dr. Liebman to our staff, patients can nowreceive the type of specialty stroke care that has previously been availableonly at large academic medical centers."

"Minutes and seconds can be critical when it comes to the treatment ofstroke and aneurysms and access to specially-trained neurosurgeons can oftenmean the difference between life and death. The Stroke and CerebrovascularCenter of New Jersey brings to this area a level of stroke treatment thathasn't been available to residents of this region," said Dr. Veznedaroglu.

The new Stroke and Cerebrovascular Center of New Jersey is part of CapitalHealth's $30 million investment to create the Center and includes newstate-of-the-art equipment for the treatment of stroke and cerebrovasculardisease that includes installation of the area's only biplane angiographysystem. This system dramatically improves the neurosurgeons' ability tovisualize vessels and conduct complex neurointerventional procedures dealingwith aneurysms, head and neck tumors and strokes.

Both Dr. Veznedaroglu and Dr. Liebman are nationally recognized academicleaders in the area of cerebrovascular care, having written chapters andarticles in various publications that are used as data for their colleaguesacross the country and invited to lecture at international conferences forphysicians around the world.

Dr. Veznedaroglu joins Capital Health as director of Neurosciences andEndovascular/Cerebrovascular Surgery. He brings to patients in this part ofthe state a portfolio of medical experience that has not previously existed.Following his fellowship training in cerebrovascular/neurointerventionalneurosurgery and neuro-critical care at Thomas Jefferson University Hospital,he became a nationally recognized Endovascular and Cerebrovascularneurosurgeon in the treatment of strokes, aneurysms, and other potentiallyfatal conditions in the brain.

Dr. Veznedaroglu has designed and invented coils for the treatment ofwide-necked aneurysms. He was the first doctor in the mid-Atlantic region touse the wingspan stent system, the first FDA-approved stent used to openclogged arteries in the brain. Intracranial atherosclerotic disease (acondition that results from too much plaque in brain arteries) accounts forabout 8 to 10 percent of strokes due to ischemia, or some 60,000 strokes inAmericans each year.

He is one of only a few physicians chosen by trial investigatorsthroughout the country to treat aneurysms with a new "glue-like" substancecalled Onyx HD500, which is injected into an aneurysm (a weak spot in a bloodvessel in the brain that balloons) where it quickly solidifies and cuts offthe area's blood supply to prevent a potentially fatal burst.

Dr. Veznedaroglu was also the first in the region to use the MerciRetriever and Penumbra devices as well as the Cordis Enterprise Stent. Acorkscrew-like device that removes blood clots in the brain caused by stroke,the Merci Retriever increases blood flow to the brain and limits the amount ofbrain damage caused by stroke, allowing patients to recover faster with lesspermanent stroke impairments. While the Merci Retriever pulls the clot out,Penumbra is a tiny vacuum device that sucks up the blood clot and restoresblood flow to the brain.

The Cordis Enterprise Stent is a new way to treat patients with wide neckaneurysms through a specially designed microstent that allows aneurysms to betreated through a minimally invasive surgery without opening the skull. Thisnew device now allows certain patients to avoid open brain surgery.

In addition to leading these and many other innovative best practices instroke and cerebrovascular care, he is the only physician in the region whocan proctor and train other physicians across the country on these samedevices. He was director of the cerebrovascular program and taught as anassociate professor in the Department of Neurosurgery at Thomas JeffersonUniversity Hospital prior to joining Capital Health.

Dr. Kenneth Liebman also joins Capital Health as director of NeurosurgicalCritical Care. After completing his neurosurgery residency at TempleUniversity Hospital, he was appointed assistant professor of neurosurgery forthe Department of Neuroscience at Seton Hall University. He receivedfellowship training in cerebrovascular surgery and interventionalneuroradiology and taught as an assistant professor of Neurosurgery at ThomasJefferson University's Jefferson Medical College.

Both Dr. Veznedaroglu and Dr. Liebman have offices at 1401Whitehorse-Mercerville Road, Suite 212 in Hamilton, NJ. They can be reachedfor non-urgent consultations at 609-588-5081.



------

Advanced Stroke Care Now Available to Area Residents

Nationally Recognized Neurosurgeons Join Capital Health

TRENTON, N.J., Nov. 18 /PRNewswire/ -- Capital Health System announcedtoday that two nationally recognized neurosurgeons, specializing incerebrovascular disease, have joined its staff, making it the leading providerin central and southern New Jersey and Bucks County Pennsylvania for advancedtreatment of stroke, aneurysms, and other critical conditions involving thebrain.

Dr. Erol Veznedaroglu and Dr. Kenneth M. Liebman, both recently joinedCapital Health, along with their team of specially trained nurses and clinicalstaff, and have opened the Stroke and Cerebrovascular Center of New Jersey.Veznedaroglu was formerly director of the Division of Neurovascular Surgeryand Endovascular Neurosurgery at Jefferson University Hospitals and Liebmanwas assistant professor of Neurosurgery at Jefferson Medical School.

"There has been a significant void in this region when it comes to theadvanced treatment of strokes and other life-threatening brain conditions,with most patients having to leave the state to get the highest level ofcare," said Al Maghazehe, CEO & President of Capital Health. "With theaddition of Dr. Veznedaroglu and Dr. Liebman to our staff, patients can nowreceive the type of specialty stroke care that has previously been availableonly at large academic medical centers."

"Minutes and seconds can be critical when it comes to the treatment ofstroke and aneurysms and access to specially-trained neurosurgeons can oftenmean the difference between life and death. The Stroke and CerebrovascularCenter of New Jersey brings to this area a level of stroke treatment thathasn't been available to residents of this region," said Dr. Veznedaroglu.

The new Stroke and Cerebrovascular Center of New Jersey is part of CapitalHealth's $30 million investment to create the Center and includes newstate-of-the-art equipment for the treatment of stroke and cerebrovasculardisease that includes installation of the area's only biplane angiographysystem. This system dramatically improves the neurosurgeons' ability tovisualize vessels and conduct complex neurointerventional procedures dealingwith aneurysms, head and neck tumors and strokes.

Both Dr. Veznedaroglu and Dr. Liebman are nationally recognized academicleaders in the area of cerebrovascular care, having written chapters andarticles in various publications that are used as data for their colleaguesacross the country and invited to lecture at international conferences forphysicians around the world.

Dr. Veznedaroglu joins Capital Health as director of Neurosciences andEndovascular/Cerebrovascular Surgery. He brings to patients in this part ofthe state a portfolio of medical experience that has not previously existed.Following his fellowship training in cerebrovascular/neurointerventionalneurosurgery and neuro-critical care at Thomas Jefferson University Hospital,he became a nationally recognized Endovascular and Cerebrovascularneurosurgeon in the treatment of strokes, aneurysms, and other potentiallyfatal conditions in the brain.

Dr. Veznedaroglu has designed and invented coils for the treatment ofwide-necked aneurysms. He was the first doctor in the mid-Atlantic region touse the wingspan stent system, the first FDA-approved stent used to openclogged arteries in the brain. Intracranial atherosclerotic disease (acondition that results from too much plaque in brain arteries) accounts forabout 8 to 10 percent of strokes due to ischemia, or some 60,000 strokes inAmericans each year.

He is one of only a few physicians chosen by trial investigatorsthroughout the country to treat aneurysms with a new "glue-like" substancecalled Onyx HD500, which is injected into an aneurysm (a weak spot in a bloodvessel in the brain that balloons) where it quickly solidifies and cuts offthe area's blood supply to prevent a potentially fatal burst.

Dr. Veznedaroglu was also the first in the region to use the MerciRetriever and Penumbra devices as well as the Cordis Enterprise Stent. Acorkscrew-like device that removes blood clots in the brain caused by stroke,the Merci Retriever increases blood flow to the brain and limits the amount ofbrain damage caused by stroke, allowing patients to recover faster with lesspermanent stroke impairments. While the Merci Retriever pulls the clot out,Penumbra is a tiny vacuum device that sucks up the blood clot and restoresblood flow to the brain.

The Cordis Enterprise Stent is a new way to treat patients with wide neckaneurysms through a specially designed microstent that allows aneurysms to betreated through a minimally invasive surgery without opening the skull. Thisnew device now allows certain patients to avoid open brain surgery.

In addition to leading these and many other innovative best practices instroke and cerebrovascular care, he is the only physician in the region whocan proctor and train other physicians across the country on these samedevices. He was director of the cerebrovascular program and taught as anassociate professor in the Department of Neurosurgery at Thomas JeffersonUniversity Hospital prior to joining Capital Health.

Dr. Kenneth Liebman also joins Capital Health as director of NeurosurgicalCritical Care. After completing his neurosurgery residency at TempleUniversity Hospital, he was appointed assistant professor of neurosurgery forthe Department of Neuroscience at Seton Hall University. He receivedfellowship training in cerebrovascular surgery and interventionalneuroradiology and taught as an assistant professor of Neurosurgery at ThomasJefferson University's Jefferson Medical College.

Both Dr. Veznedaroglu and Dr. Liebman have offices at 1401Whitehorse-Mercerville Road, Suite 212 in Hamilton, NJ. They can be reachedfor non-urgent consultations at 609-528-5081.Advanced Stroke Care Now Available to Area Residents Nationally Recognized Neurosurgeons Join Capital Health

SOURCE Capital Health System
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
HEALTHeCAREERS Network Pledges $15,000 to ASRT Fou...
S
Streamline Health to Announce Third Quarter of Fis...